Upfront riociguat and ambrisentan combination therapy for newly diagnosed pulmonary arterial hypertension: A prospective open-label trial

Autor: Weatherald, Jason, Thakrar, Mitesh V., Varughese, Rhea A., Kularatne, Mithum, Liu, Jonathan, Harper, Lea, Kiamanesh, Omid, Fine, Nowell, Orlikow, Evan, Nwaroh, Chidera, Thornton, Christina, Swiston, John, Kolkman, Lisa, Brunner, Nathan W., Helmersen, Doug, Hirani, Naushad
Zdroj: In Journal of Heart and Lung Transplantation May 2022 41(5):563-567
Databáze: ScienceDirect